Last reviewed · How we verify

Ketorolac Pill

Rothman Institute Orthopaedics · Phase 3 active Small molecule

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and decrease pain and inflammation.

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and decrease pain and inflammation. Used for Moderate to severe acute pain (short-term use), Postoperative pain management.

At a glance

Generic nameKetorolac Pill
SponsorRothman Institute Orthopaedics
Drug classNonsteroidal anti-inflammatory drug (NSAID)
TargetCOX-1, COX-2
ModalitySmall molecule
Therapeutic areaPain Management
PhasePhase 3

Mechanism of action

Ketorolac works by blocking COX-1 and COX-2 enzymes, which are responsible for producing prostaglandins that mediate pain, inflammation, and fever. By reducing prostaglandin levels, ketorolac provides rapid analgesic and anti-inflammatory effects. It is typically used for short-term management of moderate to severe acute pain.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results